Regeneron CEO 23andMe Bid - Search News

News

23andMe, Regeneron

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

CNBC on MSN · 8d

Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research

Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, privacy concerns over 23andMe's genetic data, importance of biotechnology, and more.

pharmaphorum · 3d

Former CEO wins bidding war for 23andMe, beating Regeneron

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging victorious in a bidding war for the bankrupt company.

20m

23andMe’s ex-CEO is trying to buy the company. A St. Louis judge could decide Friday.

San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in ...

23andMe Co-Founder Bids To Buy Back Data After Company Announces Bankruptcy

Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results